BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21422857)

  • 1. Maternal depression and Epstein-Barr virus reactivation in early pregnancy.
    Haeri S; Johnson N; Baker AM; Stuebe AM; Raines C; Barrow DA; Boggess KA
    Obstet Gynecol; 2011 Apr; 117(4):862-866. PubMed ID: 21422857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Epstein-Barr virus reactivation in pregnancy.
    Haeri S; Baker AM; Boggess KA
    Am J Perinatol; 2010 Oct; 27(9):715-9. PubMed ID: 20387188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy.
    Zhu P; Chen YJ; Hao JH; Ge JF; Huang K; Tao RX; Jiang XM; Tao FB
    Sci Rep; 2013 Oct; 3():3096. PubMed ID: 24172862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.
    Shi T; Huang L; Chen Z; Tian J
    J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus reactivation during pregnancy and postpartum: effects of race and racial discrimination.
    Christian LM; Iams JD; Porter K; Glaser R
    Brain Behav Immun; 2012 Nov; 26(8):1280-7. PubMed ID: 22940537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
    Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
    Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No risk of maternal EBV infection for childhood leukemia.
    Tedeschi R; Luostarinen T; Marus A; Bzhalava D; Ogmundsdottir HM; Dillner J; De Paoli P; Surcel HM; Pukkala E; Lehtinen M; Lehtinen T
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2790-2. PubMed ID: 19755652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome.
    Eskild A; Bruu AL; Stray-Pedersen B; Jenum P
    BJOG; 2005 Dec; 112(12):1620-4. PubMed ID: 16305564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Epstein-Barr virus infection and pregnancy.
    Fleisher G; Bolognese R
    J Infect Dis; 1983 Jun; 147(6):982-6. PubMed ID: 6304207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome.
    Tsai CS; Ritch R; Straus SE; Perry HD; Hsieh FY
    Arch Ophthalmol; 1990 Nov; 108(11):1572-6. PubMed ID: 2173898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N; Høier-Madsen M; Kangro H
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.
    Huggins ML; Todd I; Powell RJ
    Rheumatol Int; 2005 Apr; 25(3):183-7. PubMed ID: 14666378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic study of Epstein-Barr virus serologic assays following acute infection.
    Rea TD; Ashley RL; Russo JE; Buchwald DS
    Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.
    Werler MM; Parker SE; Hedman K; Gissler M; Ritvanen A; Surcel HM
    Am J Epidemiol; 2016 Dec; 184(12):902-912. PubMed ID: 27856447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.